2,4,5-Trifluorobenzyl bromide

2,4,5-Trifluorobenzyl bromide (CAS 157911-56-3) is manufactured directly by Hunan HuaTeng Pharmaceutical Co., Ltd. to pharmaceutical grade, used as an intermediate for Ensitrelvir (S-217622) and Sitagliptin. Ensitrelvir is an orally active 3C-like protease inhibitor developed as a COVID-19 antiviral with demonstrated activity against the Delta and Omicron variants, and the supplier offers CDMO services for COVID-19 drug manufacturing; this product is sold across North America, Central/South America, Western Europe, Australasia and Asia.